Results 121 to 130 of about 374,365 (198)

Consistency of on-the-job training implementation for subcutaneous depot medroxyprogesterone acetate in Ghana and associated healthcare worker knowledge transfer: A cross-sectional mixed-methods study. [PDF]

PLOS Glob Public Health
Porter Erlank C, Bentsi-Enchill M, Tagoe S, Amedoe JA, Stanley M, Diogo CA, Issah K.   +6 more
europepmc   +1 more source

Influence of Intramuscular Depot Medroxyprogesterone Acetate Initiation on Vaginal Microbiota in the Postpartum Period. [PDF]

Clin Infect Dis, 2021
Whitney BM, Srinivasan S, Tapia K, Muriuki EM, Chohan BH, Wallis JM, Liu C, Guthrie BL, McClelland RS, Hoffman NG, Fredricks DN, Roxby AC.   +11 more
europepmc   +1 more source

The effect of depot medroxyprogesterone acetate on tenofovir alafenamide in rhesus macaques. [PDF]

Antiviral Res, 2021
Daly MB, Sterling M, Holder A, Dinh C, Nishiura K, Khalil G, García-Lerma JG, Dobard C.   +7 more
europepmc   +1 more source

Effectiveness of levonorgestrel implant and depot medroxyprogesterone acetate injectable for women with HIV on efavirenz. [PDF]

AIDS
Mollan KR, Pence BW, Westreich D, Bula A, Lemani C, Chapola J, Hagey JM, Diepstra K, Winston J, Phiri S, Chiwoko J, Chinula L, Hosseinipour MC, Hudgens MG, Cottrell ML, Pettifor A, Jonsson-Funk M, Tang JH.   +17 more
europepmc   +1 more source

What Distinguishes Women Who Choose to Self-Inject? A Prospective Cohort Study of Subcutaneous Depot Medroxyprogesterone Acetate Users in Ghana. [PDF]

Glob Health Sci Pract, 2022
Nai D, Tobey E, Fuseini K, Kuma-Aboagye P, Jain A.   +4 more
europepmc   +1 more source

Medroxyprogesterone acetate and meningioma: a global issue

Frontiers in Global Women's Health
Noémie Roland, Sébastien Froelich, Alain Weill   +2 more
doaj   +1 more source

A Matched Case-Control Study Examining the Association Between Exposure to Depot Medroxyprogesterone Acetate and Cerebral Meningioma Using an Active Comparator. [PDF]

Curr Oncol
Griffin R, Arend R.
europepmc   +1 more source

Understanding the Acceptability of Depot Medroxyprogesterone Acetate (ANTARA) among Women of Reproductive Age from the Lens of Grassroot Level Providers in Rural and Urban Areas of Nagpur, India. [PDF]

Ann Afr Med
Lakshmi NRA, Dani A, Vithalani NJ, Ramasamy N, Dongre AR, Vijayageetha M.   +5 more
europepmc   +1 more source

Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial. [PDF]

Clin Infect Dis, 2022
Bunjun R, Ramla TF, Jaumdally SZ, Noël-Romas L, Ayele H, Brown BP, Gamieldien H, Harryparsad R, Dabee S, Nair G, Onono M, Palanee-Phillips T, Scoville CW, Heller KB, Baeten JM, Bosinger SE, Burgener A, Passmore JS, Jaspan H, Heffron R.   +19 more
europepmc   +1 more source

Cardiometabolic Risk Marker Changes in Centrally Obese Women Using Depot Medroxyprogesterone Acetate (DMPA) in Kigali, Rwanda. [PDF]

Rwanda J Med Health Sci
Kantarama E, Uwizeye D, Uwineza A.
europepmc   +1 more source